Abstract
Information on results of treatment in parkinsonism may be obtained from the patients themselves, from their relatives, i.e., family members and particularly life partners, or their general practitioners. An experienced physician, e.g., consultant neurologist, will draw comparisons with numerous parkinsonian patients in addition to his clinical observations and measurements of the patient in question. His sound and critical judgment, however, can hardly afford to ignore the patient’s own feeling, be it ever so transient and subjective. Above all, doctors are supposed primarily to take patients’ well-being into consideration, being concerned additionally with the results obtained with sophisticated measurements.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Iizuka, J. (1985). Controlled Single-Blind Trial of Budipine, L-Dopa, and Amantadine in 102 Patients with Parkinson’s Disease. In: Gerstenbrand, F., Poewe, W., Stern, G. (eds) Clinical Experiences with Budipine in Parkinson Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-95455-9_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-95455-9_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-13764-1
Online ISBN: 978-3-642-95455-9
eBook Packages: Springer Book Archive